Harrison & Co Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Harrison & Co Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.06M	Sell	14,707 -106	-0.7%	-$7.99K	1.02%	30
2022 Q3	$1.05M	Sell	14,813 -1,002	-6%	-$72.7K	1.12%	22
2022 Q2	$1.22M	Buy	15,815 +57	+0.4%	+$4.34K	1.16%	22
2022 Q1	$1.15M	Buy	15,758 +760	+5%	+$51K	1.01%	26
2021 Q4	$935K	Buy	+14,998	New	+$880K	0.79%	51

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Harrison & Co Wealth Management's BMY Position: Q4 2022 in Review

Harrison & Co Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.72% in Q4 2022, selling an estimated $7.99K and leaving 14,707 shares worth $1.06M. The position accounts for 1.02% of the portfolio, ranked #30.

Harrison & Co Wealth Management first reported a position in BMY in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.22M in Q2 2022. 2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Harrison & Co Wealth Management held 14,707 shares of Bristol-Myers Squibb worth $1.06M as of Q4 2022.
Harrison & Co Wealth Management sold 106 Bristol-Myers Squibb shares in Q4 2022, an estimated $7.99K.
Bristol-Myers Squibb made up 1.02% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #30 holding.
Harrison & Co Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 5 quarters since.
Harrison & Co Wealth Management's Bristol-Myers Squibb position peaked at $1.22M in Q2 2022.
2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.